Real-world outcomes of intranasal esketamine and intravenous ketamine induction therapy for treatment-resistant depression in a community clinic: a retrospective cohort study - Quiz - MDSpire

Real-world outcomes of intranasal esketamine and intravenous ketamine induction therapy for treatment-resistant depression in a community clinic: a retrospective cohort study

  • By

  • Patrice A. Bellanti

  • Jordan Lewis

  • Brian Seifferth

  • Daniel Z. Adams

  • July 9, 2026

  • 0 min

Share

Original Source(s)

Real-world outcomes of intranasal esketamine and intravenous ketamine induction therapy for treatment-resistant depression in a community clinic: a retrospective cohort study

  • by Patrice A. Bellanti, Jordan Lewis, Brian Seifferth, Daniel Z. Adams

  • July 9, 2026

Related Content

Treating addiction with an addictive drug: the ketamine paradox revisited

Using Urine Drug Testing to Track Xylazine-Fentanyl Copositivity in a Changing Drug Supply

Loneliness, rumination, and adolescent psychological crisis in China: a pilot moderated mediation study